The Veterinary clinics of North America. Equine practice2003; 19(1); 63-vi; doi: 10.1016/s0749-0739(02)00067-6

Recurrent airway obstruction–heaves.

Abstract: Heaves, or recurrent airway obstruction (RAO), is a chronic respiratory disease featuring lower airway inflammation, bronchoconstriction, and mucus accumulation. Inhaled organic dusts and T helper 2 type immunologic reactions are involved in the complex pathophysiology of RAO. Clinical signs vary and alternate with remission periods. The diagnosis is often based on history and clinical examination in severe cases, but bronchoalveolar lavage may be useful for the detection of early cases. The most important aspect of treatment is to avoid exposure to allergens. Corticosteroids may be administered systemically or by inhalation in combination with bronchodilators and environmental control.
Publication Date: 2003-05-16 PubMed ID: 12747662DOI: 10.1016/s0749-0739(02)00067-6Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study explores recurrent airway obstruction (RAO), also known as ‘heaves’. The authors delve into the disease’s cause linked to inhaled organic dusts and an immune reaction, its symptoms which are intermittent, and diagnosis which can be determined by case history or medical examination. They also discuss potential treatments including the avoidance of allergens and the use of corticosteroids with bronchodilators.

What is Recurrent Airway Obstruction (RAO)?

  • Recurrent airway obstruction, also known as heaves, refers to a chronic respiratory disease typically associated with lower airway inflammation, bronchoconstriction, and mucus accumulation.
  • Essentially, this condition is comparable to asthma in humans, likened to complications in the lungs that cause breathing difficulties.

Causes of RAO

  • The researchers highlight that the complex pathophysiology of RAO is linked to interactions between inhaled organic dusts and immune responses, notably T helper 2 type immunologic reactions.
  • In layman’s terms, this means the disease is brought about when a horse inhales certain types of dust, leading to an immune reaction in the body.

Symptoms and Diagnosis

  • Clinical signs of RAO can vary significantly and alternate with periods of remission, making the disease cyclical and unpredictable to some extent.
  • Diagnosis typically rests on a horse’s medical history and a clinical examination, particularly in severe cases where the symptoms are more noticeable.
  • However, for early detection of this condition, bronchoalveolar lavage (a medical procedure involving examination of the bronchi) may be useful.

Treatment for RAO

  • The most critical factor in treating RAO is avoiding exposure to the allergens that trigger the condition in the first place.
  • Medical treatment typically involves administration of corticosteroids, either systemically or through inhalation, in conjunction with bronchodilators.
  • The bronchodilators help relax the muscles around the bronchi, improving airflow and relieving symptoms of RAO. The corticosteroids, on the other hand, work by reducing inflammation.
  • As an additional therapy, control of the horse’s environment can be beneficial in managing the disease.

Cite This Article

APA
Lu00e9guillette R. (2003). Recurrent airway obstruction–heaves. Vet Clin North Am Equine Pract, 19(1), 63-vi. https://doi.org/10.1016/s0749-0739(02)00067-6

Publication

ISSN: 0749-0739
NlmUniqueID: 8511904
Country: United States
Language: English
Volume: 19
Issue: 1
Pages: 63-vi

Researcher Affiliations

Lu00e9guillette, Renaud
  • Meakins-Christie Laboratories, McGill University, 3626 St. Urbain Street, Montreal, Quebec H2X 2P2, Canada. renaud.leguillette@mail.mcgill.ca

MeSH Terms

  • Adrenal Cortex Hormones / therapeutic use
  • Airway Obstruction / diagnosis
  • Airway Obstruction / drug therapy
  • Airway Obstruction / pathology
  • Airway Obstruction / veterinary
  • Animals
  • Bronchoalveolar Lavage / veterinary
  • Chronic Disease
  • Horse Diseases / diagnosis
  • Horse Diseases / drug therapy
  • Horse Diseases / pathology
  • Horses
  • Mucus / metabolism
  • Prognosis
  • Recurrence
  • Respiratory Function Tests / veterinary
  • Respiratory Hypersensitivity / diagnosis
  • Respiratory Hypersensitivity / drug therapy
  • Respiratory Hypersensitivity / pathology
  • Respiratory Hypersensitivity / veterinary

Citations

This article has been cited 29 times.
  1. Simu00f5es J, Batista M, Tilley P. The Immune Mechanisms of Severe Equine Asthma-Current Understanding and What Is Missing.. Animals (Basel) 2022 Mar 16;12(6).
    doi: 10.3390/ani12060744pubmed: 35327141google scholar: lookup
  2. Lo Feudo CM, Stucchi L, Alberti E, Conturba B, Zucca E, Ferrucci F. Intradermal Testing Results in Horses Affected by Mild-Moderate and Severe Equine Asthma.. Animals (Basel) 2021 Jul 13;11(7).
    doi: 10.3390/ani11072086pubmed: 34359214google scholar: lookup
  3. Morini M, Peli A, Rinnovati R, Magazzu00f9 G, Romagnoli N, Spadari A, Pietra M. Immunohistochemical Expression of Neurokinin-A and Interleukin-8 in the Bronchial Epithelium of Horses with Severe Equine Asthma Syndrome during Asymptomatic, Exacerbation, and Remission Phase.. Animals (Basel) 2021 May 12;11(5).
    doi: 10.3390/ani11051376pubmed: 34066204google scholar: lookup
  4. Slowikowska M, Bajzert J, Miller J, Stefaniak T, Niedzwiedz A. The Dynamics of Circulating Immune Complexes in Horses with Severe Equine Asthma.. Animals (Basel) 2021 Apr 2;11(4).
    doi: 10.3390/ani11041001pubmed: 33918401google scholar: lookup
  5. Christmann U, Hancock CL, Poole CM, Emery AL, Poovey JR, Hagg C, Mattson EA, Scarborough JJ, Christopher JS, Dixon AT, Craney DJ, Wood PL. Dynamics of DHA and EPA supplementation: incorporation into equine plasma, synovial fluid, and surfactant glycerophosphocholines.. Metabolomics 2021 Apr 17;17(5):41.
    doi: 10.1007/s11306-021-01792-5pubmed: 33866431google scholar: lookup
  6. Couetil L, Cardwell JM, Leguillette R, Mazan M, Richard E, Bienzle D, Bullone M, Gerber V, Ivester K, Lavoie JP, Martin J, Moran G, Niedu017awiedu017a A, Pusterla N, Swiderski C. Equine Asthma: Current Understanding and Future Directions.. Front Vet Sci 2020;7:450.
    doi: 10.3389/fvets.2020.00450pubmed: 32903600google scholar: lookup
  7. Bazzano M, Laghi L, Zhu C, Magi GE, Tesei B, Laus F. Respiratory metabolites in bronchoalveolar lavage fluid (BALF) and exhaled breath condensate (EBC) can differentiate horses affected by severe equine asthma from healthy horses.. BMC Vet Res 2020 Jul 8;16(1):233.
    doi: 10.1186/s12917-020-02446-9pubmed: 32641035google scholar: lookup
  8. Kaiser-Thom S, Hilty M, Gerber V. Effects of hypersensitivity disorders and environmental factors on the equine intestinal microbiota.. Vet Q 2020 Dec;40(1):97-107.
    doi: 10.1080/01652176.2020.1745317pubmed: 32189583google scholar: lookup
  9. MacDonald ES, Barrett JG. The Potential of Mesenchymal Stem Cells to Treat Systemic Inflammation in Horses.. Front Vet Sci 2019;6:507.
    doi: 10.3389/fvets.2019.00507pubmed: 32039250google scholar: lookup
  10. Sheats MK, Davis KU, Poole JA. Comparative Review of Asthma in Farmers and Horses.. Curr Allergy Asthma Rep 2019 Oct 10;19(11):50.
    doi: 10.1007/s11882-019-0882-2pubmed: 31599358google scholar: lookup
  11. Varegg MS, Klu00f8veru00f8d KM, Austnes MK, Siwinska N, Slowikowska M, Zak A, Niedzwiedz A. The effect of single pretreatment with salbutamol on recovery of bronchoalveolar lavage fluid in horses with suspected or confirmed severe equine asthma.. J Vet Intern Med 2019 Mar;33(2):976-980.
    doi: 10.1111/jvim.15359pubmed: 30707780google scholar: lookup
  12. Lau N, Norman A, Smith MJ, Sarkar A, Gao Z. Association between Traffic Related Air Pollution and the Development of Asthma Phenotypes in Children: A Systematic Review.. Int J Chronic Dis 2018;2018:4047386.
    doi: 10.1155/2018/4047386pubmed: 30631772google scholar: lookup
  13. Lavoie JP, Leclere M, Rodrigues N, Lemos KR, Bourzac C, Lefebvre-Lavoie J, Beauchamp G, Albrecht B. Efficacy of inhaled budesonide for the treatment of severe equine asthma.. Equine Vet J 2019 May;51(3):401-407.
    doi: 10.1111/evj.13018pubmed: 30203854google scholar: lookup
  14. Barton AK, Schulze T, Doherr MG, Gehlen H. Influence of bronchoalveolar lavage on thoracic radiography in the horse.. J Vet Sci 2018 Jul 31;19(4):563-569.
    doi: 10.4142/jvs.2018.19.4.563pubmed: 29486534google scholar: lookup
  15. Bond SL, Timsit E, Workentine M, Alexander T, Lu00e9guillette R. Upper and lower respiratory tract microbiota in horses: bacterial communities associated with health and mild asthma (inflammatory airway disease) and effects of dexamethasone.. BMC Microbiol 2017 Aug 23;17(1):184.
    doi: 10.1186/s12866-017-1092-5pubmed: 28835202google scholar: lookup
  16. Henru00edquez C, Moru00e1n G, Carrasco C, Sarmiento J, Barru00eda M, Folch H, Uberti B. Modulatory role of regulatory T cells in a murine model of severe equine asthma.. BMC Vet Res 2017 Apr 28;13(1):117.
    doi: 10.1186/s12917-017-1037-0pubmed: 28454585google scholar: lookup
  17. Niedzwiedz A, Borowicz H, Januszewska L, Markiewicz-Gorka I, Jaworski Z. Serum 8-hydroxy-2-deoxyguanosine as a marker of DNA oxidative damage in horses with recurrent airway obstruction.. Acta Vet Scand 2016 Jun 7;58(1):38.
    doi: 10.1186/s13028-016-0215-6pubmed: 27267076google scholar: lookup
  18. Niedzwiedz A, Jaworski Z. Oxidant-antioxidant status in the blood of horses with symptomatic recurrent airway obstruction (RAO).. J Vet Intern Med 2014 Nov-Dec;28(6):1845-52.
    doi: 10.1111/jvim.12452pubmed: 25231643google scholar: lookup
  19. Cu00f4tu00e9 O, Clark ME, Viel L, Labbu00e9 G, Seah SY, Khan MA, Douda DN, Palaniyar N, Bienzle D. Secretoglobin 1A1 and 1A1A differentially regulate neutrophil reactive oxygen species production, phagocytosis and extracellular trap formation.. PLoS One 2014;9(4):e96217.
    doi: 10.1371/journal.pone.0096217pubmed: 24777050google scholar: lookup
  20. Niedzwiedz A, Jaworski Z, Tykalowski B, Smialek M. Neutrophil and macrophage apoptosis in bronchoalveolar lavage fluid from healthy horses and horses with recurrent airway obstruction (RAO).. BMC Vet Res 2014 Jan 24;10:29.
    doi: 10.1186/1746-6148-10-29pubmed: 24460911google scholar: lookup
  21. Bosshard S, Gerber V. Evaluation of coughing and nasal discharge as early indicators for an increased risk to develop equine recurrent airway obstruction (RAO).. J Vet Intern Med 2014 Mar-Apr;28(2):618-23.
    doi: 10.1111/jvim.12279pubmed: 24417562google scholar: lookup
  22. Sarmiento J, Perez B, Morales N, Henriquez C, Vidal L, Folch H, Galecio JS, Moru00e1n G. Apoptotic effects of tamoxifen on leukocytes from horse peripheral blood and bronchoalveolar lavage fluid.. Vet Res Commun 2013 Dec;37(4):333-8.
    doi: 10.1007/s11259-013-9571-0pubmed: 23846832google scholar: lookup
  23. Fugazzola M, Barton AK, Niedorf F, Kietzmann M, Ohnesorge B. Non-genomic action of beclomethasone dipropionate on bronchoconstriction caused by leukotriene C4 in precision cut lung slices in the horse.. BMC Vet Res 2012 Sep 10;8:160.
    doi: 10.1186/1746-6148-8-160pubmed: 22963524google scholar: lookup
  24. Abraham G, Zizzadoro C, Kacza J, Ellenberger C, Abs V, Franke J, Schoon HA, Seeger J, Tesfaigzi Y, Ungemach FR. Growth and differentiation of primary and passaged equine bronchial epithelial cells under conventional and air-liquid-interface culture conditions.. BMC Vet Res 2011 Jun 7;7:26.
    doi: 10.1186/1746-6148-7-26pubmed: 21649893google scholar: lookup
  25. Moran G, Buechner-Maxwell VA, Folch H, Henriquez C, Galecio JS, Perez B, Carrasco C, Barria M. Increased apoptosis of CD4 and CD8 T lymphocytes in the airways of horses with recurrent airway obstruction.. Vet Res Commun 2011 Oct;35(7):447-56.
    doi: 10.1007/s11259-011-9482-xpubmed: 21594641google scholar: lookup
  26. Patel AC, Brett TJ, Holtzman MJ. The role of CLCA proteins in inflammatory airway disease.. Annu Rev Physiol 2009;71:425-49.
  27. Pearson W, Charch A, Brewer D, Clarke AF. Pilot study investigating the ability of an herbal composite to alleviate clinical signs of respiratory dysfunction in horses with recurrent airway obstruction.. Can J Vet Res 2007 Apr;71(2):145-51.
    pubmed: 17479778
  28. Art T, Franck T, Lekeux P, de Moffarts B, Couu00ebtil L, Becker M, Kohnen S, Deby-Dupont G, Serteyn D. Myeloperoxidase concentration in bronchoalveolar lavage fluid from healthy horses and those with recurrent airway obstruction.. Can J Vet Res 2006 Oct;70(4):291-6.
    pubmed: 17042382
  29. Anton F, Leverkoehne I, Mundhenk L, Thoreson WB, Gruber AD. Overexpression of eCLCA1 in small airways of horses with recurrent airway obstruction.. J Histochem Cytochem 2005 Aug;53(8):1011-21.
    doi: 10.1369/jhc.4A6599.2005pubmed: 15879574google scholar: lookup